Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Persistent depressive disorder (PDD) is defined as a depressive disorder with a minimum illness duration of two years, including four diagnostic subgroups (dysthymia, chronic major depression, recurrent major depression with incomplete remission between episodes, and double depression). Persistent forms of depression represent a substantial proportion of depressive disorders, with a lifetime prevalence ranging from 3% to 6% in the Western world. Growing evidence indicates that PDD responds well to several acute interventions, such as combined psychological and pharmacological treatments. Yet, given the high rates of relapse and recurrences of depression following response to acute treatment, long-term continuation and maintenance therapy are of great importance. To date, there has been no evidence synthesis available on continuation and maintenance treatments of PDDs. OBJECTIVES: To assess the effects of pharmacological and psychological (either alone or combined) continuation and maintenance treatments for persistent depressive disorder, in comparison with each other, placebo (drug/attention placebo/non-specific treatment control), and treatment as usual (TAU). Continuation treatments are defined as treatments given to currently remitted people (remission is defined as depressive symptoms dropping below case level) or to people who previously responded to an antidepressant treatment. Maintenance therapy is given during recovery (which is defined as remission lasting longer than six months). SEARCH METHODS: We searched Ovid MEDLINE (1950- ), Embase (1974- ), PsycINFO (1967- ) and the Cochrane Central Register of Controlled Trials (CENTRAL) to 28 September 2018. An earlier search of these databases was also conducted for RCTs via the Cochrane Common Mental Disorders Controlled Trial Register (CCMD-CTR) (all years to 11 Dec 2015). In addition we searched grey literature resources as well as the international trial registers ClinicalTrials.gov and ICTRP to 28 September 2018. We screened reference lists of included studies and contacted the first author of all included studies. SELECTION CRITERIA: We included randomized (RCTs) and non-randomized controlled trials (NRCTs) in adults with formally diagnosed PDD, receiving pharmacological, psychological, or combined continuation and maintenance interventions. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies and extracted and analyzed data. The primary efficacy outcome was relapse/recurrence rate of depression. The primary acceptance outcome was dropout due to any reason other than relapse/recurrence. We performed random-effects meta-analyses using risk ratios (RR) for dichotomous outcomes and mean differences (MD) for continuous outcomes, with 95% confidence intervals (CI). MAIN RESULTS: We included 10 studies (seven RCTs, three NRCTs) involving 840 participants in this review, from which five studies investigated continuation treatments and five studies investigated maintenance treatments. Overall, the included studies were at low-to-moderate risk of bias. For the three NRCTs, the most common source of risk of bias was selection of reported results. For the seven RCTs, the most common sources of risk of bias was non-blinding of outcome assessment and other bias (especially conflict of interest due to pharmaceutical sponsoring).Pharmacological continuation and maintenance therapiesThe most common comparison was antidepressant medication versus tablet placebo (five studies). Participants taking antidepressant medication were probably less likely to relapse or to experience a recurrent episode compared to participants in the placebo group at the end of the intervention (13.9% versus 33.8%, RR 0.41, 95% CI 0.21 to 0.79; participants = 383; studies = 4; I² = 54%, moderate quality evidence). Overall dropout rates may be similar between participants in the medication and placebo group (23.0% versus 25.5%, RR 0.90, 95% CI 0.39 to 2.11; RCTs = 4; participants = 386; I² = 64%, low quality evidence). However, sensitivity analyses showed that the primary outcome (rate of relapse/recurrence) showed no evidence of a difference between groups when only including studies with low risk of bias.None of the studies compared pharmacological or psychological treatments versus TAU.Psychological continuation and maintenance therapiesOne study compared psychological therapies versus attention placebo/non-specific control. One study compared psychotherapy with medication. The results of the studies including psychotherapy might indicate that continued or maintained psychotherapy could be a useful intervention compared to no treatment or antidepressant medication. However, the body of evidence for these comparisons was too small and uncertain to draw any high quality conclusions.Combined psychological and pharmacological continuation and maintenance therapiesThree studies compared combined psychological and pharmacological therapies with pharmacol
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686 · cited 4×
“The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial.”
BackgroundInfluentialKirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163 · cited 2×
“However, in future versions of this review, differences between subgroups should be tested formally (Bucher 1997; Deeks 2008; Song 2003), and all meta-regression analyses should be performed using the restricted maximum likelihood estimate method, a recommended random-effects approach that accounts…”
MethodFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 5×
“…studies had to be excluded because they did not define clear response or remission criteria for entering the next treatment phase which we required for inclusion in the review as response or remission are considered as accurate criteria of continuation or maintenance treatments (Frank 1991).”
BackgroundInfluentialNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 2×
“Berton 2006 Berton O, Nestler EJ.”
BackgroundKeller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., Markowitz, J. C., Nemeroff, C. B., Russell, J. M., Thase, M. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422001 · Cited by 1,331
Psychological Treatments That Cause Harm
Lilienfeld, S. O. (2007) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2007.00029.x · Cited by 959
Keller, M. B. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100053010 · Cited by 864
Piet, J., & Hougaard, E. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.05.002 · Cited by 807 · cited 2×
“Piet 2011 Piet J, Hougaard E.”
BackgroundVittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.475 · Cited by 551 · cited 14×
“Vittengl 2007 Vittengl JR, Clark LA, Dunn TW, Jarrett RB. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects.”
BackgroundMethodResultInfluentialCuijpers, P., Sijbrandij, M., Koole, S. L., Andersson, G., Beekman, A. T., & Reynolds, C. F. (2013) · World Psychiatry · doi:10.1002/wps.20038 · Cited by 540 · cited 2×
“Cuijpers 2013 Cuijpers P, Sijbrandij M, Koole Sander L, Andersson G, Beekman Aartjan T, Reynolds Charles F.”
Rush, A. J., Carmody, T., & Reimitz, P. (2000) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.79 · Cited by 427
Six-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Fava, G. A., Ruini, C., Rafanelli, C., Finos, L., Conti, S., & Grandi, S. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1872 · Cited by 392
Nutt, D., Demyttenaere, K., Janka, Z., Aarre, T., Bourin, M., Canonico, P. L., Carrasco, J. L., & Stahl, S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106069938 · Cited by 366
Psychotherapy for chronic major depression and dysthymia: A meta-analysis
Cuijpers, P., van Straten, A., Schuurmans, J., van Oppen, P., Hollon, S. D., & Andersson, G. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.09.003 · Cited by 320 · cited 2×
“Cuijpers 2010 Cuijpers P, van Straten A, Schuurmans J, van Oppen P, Hollon Steven D, Andersson G. Psychotherapy for chronic major depression and dysthymia: a meta-analysis.”
BackgroundTreatment for chronic depression using Cognitive Behavioral Analysis System of Psychotherapy (CBASP)
McCullough, J. P. (2003) · Journal of Clinical Psychology · doi:10.1002/jclp.10176 · Cited by 288
Bockting, C. L. H., DELTA Study Group, Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.4.647 · Cited by 249
Ladwig, I., Rief, W., & Nestoriuc, Y. (2014) · Verhaltenstherapie · doi:10.1159/000367928 · Cited by 227 · cited 2×
“…to a patient including symptoms of all body parts (e.g. headache, dizziness, dry mouth); psychological symptoms (e.g. depressed mood, suicidal thoughts); and psychosocial, legal, and economic consequences (e.g. conflicts with the partner, stigmatization) (Ladwig 2014; Nebeker 2004; Rief 2011).”
BackgroundBrowne, G., Steiner, M., Roberts, J., Gafni, A., Byrne, C., Dunn, E., Bell, B., Mills, M., Chalklin, L., Wallik, D., et al. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00343-3 · Cited by 199 · cited 2×
“Browne 2002 Browne G, Steiner M, Roberts J, Gafni A, Byrne C, Dunn E, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs.”
BackgroundStangier, U., Hilling, C., Heidenreich, T., Risch, A. K., Barocka, A., Schlösser, R., Kronfeld, K., Ruckes, C., Berger, H., Röschke, J., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060734 · Cited by 174 · cited 2×
“…disorder or long-term treatments for acute depressive episodes, some studies have addressed the effectiveness of longterm treatments of persistent depressive disorder (Gelenberg 2003; Harrison 1986; Keller 1998a; Klein 2004; Kocsis 1996; Kocsis 2003; Koran 2001; Rouillon 1989; Stangier 2013).”
BackgroundMethodGuidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
Continuation and maintenance treatments for depression in older people
Wilkinson, P., & Izmeth, Z. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006727.pub3 · Cited by 151
A cognitive neuropsychological model of antidepressant drug action
Pringle, A., Browning, M., Cowen, P. J., & Harmer, C. J. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.022 · Cited by 130
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy
Nutt, D. J., & Sharpe, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107086283 · Cited by 123 · cited 2×
“Nutt 2008 Nutt DJ, Sharpe M. Uncritical positive regard?”
BackgroundKriston, L., von Wolff, A., Westphal, A., Hölzel, L. P., & Härter, M. (2014) · Depression and Anxiety · doi:10.1002/da.22236 · Cited by 119 · cited 3×
“A previous review investigated the efficacy and acceptability of acute treatments in PDD by applying network meta-analytic methods, showing that several antidepressant medications were superior to placebo, and that several evidence-based treatments exist (Kriston 2014).”
BackgroundMethodSelf-citationKeller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Meta-analysis of relapse prevention antidepressant trials in depressive disorders
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048671003705441 · Cited by 100
Michalak, J., Schultze, M., Heidenreich, T., & Schramm, E. (2015) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000042 · Cited by 86 · cited 2×
“Michalak 2015 No response during acute treatment required for entering MBCT. Murray 2010 No response during acute treatment required to enter intervention.”
BackgroundGelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., Kornstein, S. G., Dunner, D. L., Markowitz, J. C., Hirschfeld, R. M. A., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01971-6 · Cited by 76
Huijbers, M. J., Spinhoven, P., Spijker, J., Ruhé, H. G., van Schaik, D. J. F., van Oppen, P., Nolen, W. A., Ormel, J., Kuyken, W., van der Wilt, G. J., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.023 · Cited by 43 · cited 2×
“Huijbers 2015 {published data only} Huijbers MJ, Spinhoven P, Spijker J, Ruhe HG, van Schaik DJ, van Oppen P, et al. Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: randomised controlled trial.”
Backgroundvan Aalderen, J. R., Donders, A. R. T., Peffer, K., & Speckens, A. E. M. (2015) · Depression and Anxiety · doi:10.1002/da.22369 · Cited by 23
Omidi, A., Hamidian, S., Mousavinasab, S. M., & Naziri, G. (2013) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.8024 · Cited by 22 · cited 2×
“Hamidian 2013 No response during acute treatment required for entering MBCT. Hellerstein 1994 Acute treatment with long-term follow-up Hellerstein 2015 No comparator (pilot study) Hellerstein 2017 No response during acute treatment required to enter continuation trial.”
BackgroundMethodPetersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., et al. (2010) · Cognitive Therapy and Research · doi:10.1007/s10608-007-9166-6 · Cited by 14 · cited 4×
“Several RCTs have supported the effectiveness of continuation and maintenance therapies for depression (Browne 2002; Jarrett 2001; Jarrett 2013; Keller 2007; Klein 2004; Petersen 2010; Vittengl 2009).”
BackgroundInfluential
Cited by
García-Gutiérrez, M. S., Navarrete, F., Gasparyan, A., Austrich-Olivares, A., Sala, F., & Manzanares, J. (2020) · Biomolecules · doi:10.3390/biom10111575 · Cited by 306
Schramm, E., Klein, D. N., Elsaesser, M., Furukawa, T. A., & Domschke, K. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30099-7 · Cited by 255
Management of Depression in Adults: A Review
Simon, G. E., Moise, N., & Mohr, D. C. (2024) · JAMA · doi:10.1001/jama.2024.5756 · Cited by 234
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Pilkington, K., & Wieland, L. S. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03038-8 · Cited by 31
“Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults [64] 2019 Herbal (St.”
Background
Metadata
- Authors
- Machmutow, K., Meister, R., Jansen, A., Kriston, L., Watzke, B., Härter, M. C., & Liebherz, S.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2019-05-20
- Volume
- 2019
- Issue
- 5
- Pages
- CD012855-CD012855
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2946086630
- Cited by
- 65
- References
- 35
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.